United States · 
Who invested in Autobahn Therapeutics?
Autobahn Therapeutics's investors include Insight Partners, Canaan, ARCH Venture Partners, Samsara BioCapital and S32, and 1 more on record.
United States · Series C startup
Who invested in Autobahn Therapeutics
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2024, from 1 source
- Latest round
- Series C, $100MJul 2024
- Investors
- 6
The rounds
- Jul 2024Series C$100M
Source recordedSEC filing: $101M sold, first sale Jun 2024
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Autobahn Therapeutics
How much has Autobahn Therapeutics raised?
Autobahn Therapeutics has raised $100M across 1 round since 2024.
When did Autobahn Therapeutics last raise?
Autobahn Therapeutics's most recent round was a Series C of $100M in Jul 2024.
What was Autobahn Therapeutics's biggest round?
Its most recent round, $100M in Jul 2024, is also its largest on record.
Who backed Autobahn Therapeutics first?
Autobahn Therapeutics's first round on record, in Jul 2024, was backed by Insight Partners, Canaan and ARCH Venture Partners and 3 others.
What stage is Autobahn Therapeutics at?
Autobahn Therapeutics's latest named round is a Series C, in Jul 2024.
Where is Autobahn Therapeutics based?
Autobahn Therapeutics is based in the United States.
Companies like Autobahn Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.